Company intelligence / Profile preview

SSCI Leading Fund

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Sino-Science Leading Capital, also known as Guoke Jiahe, is a prominent venture capital firm founded in 2011 and backed by the Chinese Academy of Sciences (CAS). The firm manages the SSCI Leading Fund and specializes in early and growth-stage investments in high-tech sectors, with a primary focus on life sciences, healthcare, and information technology. By leveraging the extensive research network and technical expertise of CAS, the firm provides strategic capital and operational support to innovative startups in China. Its healthcare portfolio includes significant investments in biotechnology, medical diagnostics, and advanced medical devices, making it a key institutional investor in the region's life sciences ecosystem.

Industry: Investors

Partnerships

Chinese Academy of Sciences

Beyond the preview

Go deeper on SSCI Leading Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SSCI Leading Fund.

Explore the full profile